Molecular-Targeted Therapies for Hematologic Malignancies

• Molecular-Targeted Therapies for Hematologic Malignancies, Kevin D. Bunting, Cheng-Kui Qu, and Michael H. Tomasson
  Volume 2012 (2012), Article ID 606423, 2 pages
• Gab Adapter Proteins as Therapeutic Targets for Hematologic Disease, Sheetal Verma, Tamisha Vaughan, and Kevin D. Bunting
  Volume 2012 (2012), Article ID 380635, 10 pages
• Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia, Xiaoling Liu, Himalee Sabnis, Kevin D. Bunting, and Cheng-Kui Qu
  Volume 2012 (2012), Article ID 308252, 7 pages
• Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies, Junko Okabe-Kado, Takashi Kasukabe, and Yasuhiko Kaneko
  Volume 2012 (2012), Article ID 879368, 10 pages
• The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias, Flora Tzifi, Christina Economopoulou, Dimitrios Gourgiotis, Alexandros Ardavanis, Sotirios Papageorgiou, and Andreas Scorilas
  Volume 2012 (2012), Article ID 524308, 15 pages
• Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia, Philipp Koehler, Patrick Schmidt, Andreas A. Hombach, Michael Hallek, and Hinrich Abken
  Volume 2012 (2012), Article ID 595060, 13 pages
• Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy, Amir T. Fathi and Omar Abdel-Wahab
  Volume 2012 (2012), Article ID 469592, 12 pages
• The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas, Pinelopi Argyriou, Panagiota Economopoulou, and Sotirios Papageorgiou
  Volume 2012 (2012), Article ID 435342, 13 pages